RaySearch Laboratories AB (0GRZ) Financial Statements
0 Followers
RaySearch Laboratories AB Financial Overview
RaySearch Laboratories AB's market cap is currently kr5.71B. The company's EPS TTM is kr6.02; its P/E ratio is 28.82; and it has a dividend yield of 1.82%. RaySearch Laboratories AB is estimated to report earnings on February 10, 2027, and the estimated EPS forecast is kr2.81. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 1.34B | kr 1.19B | kr 1.02B | kr 843.65M | kr 641.67M |
| Gross Profit | kr 951.40M | kr 1.09B | kr 915.58M | kr 748.66M | kr 591.28M |
| Operating Income | kr 321.80M | kr 260.49M | kr 114.88M | kr 42.74M | kr -52.64M |
| EBITDA | kr 612.80M | kr 571.25M | kr 405.94M | kr 340.85M | kr 197.36M |
| Net Income | kr 227.80M | kr 203.51M | kr 81.57M | kr 23.78M | kr -47.31M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 407.30M | kr 462.74M | kr 343.68M | kr 160.27M | kr 102.53M |
| Total Assets | kr 1.99B | kr 2.09B | kr 1.95B | kr 1.88B | kr 1.74B |
| Total Debt | kr 394.80M | kr 471.93M | kr 529.36M | kr 555.39M | kr 561.40M |
| Net Debt | kr -12.50M | kr 9.19M | kr 185.68M | kr 395.12M | kr 458.86M |
| Total Liabilities | kr 1.01B | kr 1.21B | kr 1.22B | kr 1.22B | kr 1.09B |
| Stockholders' Equity | kr 985.30M | kr 876.71M | kr 735.23M | kr 657.16M | kr 628.31M |
| Cash Flow | |||||
| Free Cash Flow | kr 358.90M | kr 267.69M | kr 246.60M | kr 125.28M | kr -17.06M |
| Operating Cash Flow | kr 387.00M | kr 485.23M | kr 455.93M | kr 356.78M | kr 238.16M |
| Investing Cash Flow | kr -228.10M | kr -217.54M | kr -209.33M | kr -231.50M | kr -237.63M |
| Financing Cash Flow | kr -179.60M | kr -159.78M | kr -56.35M | kr -72.49M | kr -72.23M |
Currency in SEK
